International
Centanafadine: New ADHD Treatment Approved in the United States
The new medication centanafadine is not yet available in France, according to specialists.
Centanafadine, a promising medication for the treatment of ADHD, has recently been approved in the United States. This treatment is distinguished by its innovative mode of action, offering new perspectives for affected patients.
However, French specialists emphasize that this medication is not among the available options in France. They highlight the scarcity of molecules available in the country for treating this disorder, pointing out a gap in the therapeutic offerings.